Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 2
1982 1
1988 1
1990 1
1993 1
1998 2
1999 2
2002 4
2004 1
2005 1
2007 5
2008 2
2009 2
2010 3
2011 4
2012 5
2013 8
2014 7
2015 11
2016 17
2017 15
2018 29
2019 40
2020 29
2021 51
2022 77
2023 79
2024 25

Text availability

Article attribute

Article type

Publication date

Search Results

375 results

Results by year

Filters applied: . Clear all
Page 1
Identifying and visualising multimorbidity and comorbidity patterns in patients in the English National Health Service: a population-based study.
Kuan V, Denaxas S, Patalay P, Nitsch D, Mathur R, Gonzalez-Izquierdo A, Sofat R, Partridge L, Roberts A, Wong ICK, Hingorani M, Chaturvedi N, Hemingway H, Hingorani AD; Multimorbidity Mechanism and Therapeutic Research Collaborative (MMTRC). Kuan V, et al. Lancet Digit Health. 2023 Jan;5(1):e16-e27. doi: 10.1016/S2589-7500(22)00187-X. Epub 2022 Nov 29. Lancet Digit Health. 2023. PMID: 36460578 Free article.
Efficacy of a food supplement based on S-adenosyl methionine and probiotic strains in subjects with subthreshold depression and mild-to-moderate depression: A monocentric, randomized, cross-over, double-blind, placebo-controlled clinical trial.
Ullah H, Di Minno A, Esposito C, El-Seedi HR, Khalifa SAM, Baldi A, Greco A, Santonastaso S, Cioffi V, Sperandeo R, Sacchi R, Daglia M. Ullah H, et al. Biomed Pharmacother. 2022 Dec;156:113930. doi: 10.1016/j.biopha.2022.113930. Epub 2022 Oct 27. Biomed Pharmacother. 2022. PMID: 36411659 Free article. Clinical Trial.
Targeting Adenosine Receptors in Neurological Diseases.
Atif M, Alsrhani A, Naz F, Imran M, Imran M, Ullah MI, Alameen AAM, Gondal TA, Raza Q. Atif M, et al. Cell Reprogram. 2021 Apr;23(2):57-72. doi: 10.1089/cell.2020.0087. Cell Reprogram. 2021. PMID: 33861641 Review.
Therefore, modulations of these receptors by using antagonists of these receptors or SAM (S-adenosylmethionine) therapy as an epigenetic tool could be useful in reversing the complications of these disorders. ...
Therefore, modulations of these receptors by using antagonists of these receptors or SAM (S-adenosylmethionine) therapy as an …
375 results